WallStreetZenWallStreetZen

NASDAQ: NVNO
Envveno Medical Corp Stock

$6.05-0.15 (-2.42%)
Updated Feb 27, 2024
NVNO Price
$6.05
Fair Value Price
$0.25
Market Cap
$80.57M
52 Week Low
$2.51
52 Week High
$6.77
P/E
-2.81x
P/B
3.23x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$24.05M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.13
Operating Cash Flow
-$18M
Beta
0.91
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NVNO Overview

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NVNO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NVNO ($6.05) is overvalued by 2,293.15% relative to our estimate of its Fair Value price of $0.25 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
NVNO ($6.05) is not significantly undervalued (2,293.15%) relative to our estimate of its Fair Value price of $0.25 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
NVNO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NVNO due diligence checks available for Premium users.

Be the first to know about important NVNO news, forecast changes, insider trades & much more!

NVNO News

Valuation

NVNO fair value

Fair Value of NVNO stock based on Discounted Cash Flow (DCF)
Price
$6.05
Fair Value
$0.25
Overvalued by
2,293.15%
NVNO ($6.05) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NVNO ($6.05) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NVNO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NVNO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.81x
Industry
32.65x
Market
36.02x

NVNO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.23x
Industry
4.02x
NVNO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NVNO's financial health

Profit margin

Revenue
$0.0
Net Income
-$5.0M
Profit Margin
0%
NVNO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$28.1M
Liabilities
$3.2M
Debt to equity
0.13
NVNO's short-term assets ($26.22M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NVNO's short-term assets ($26.22M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NVNO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NVNO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.2M
Investing
$4.4M
Financing
$0.0
NVNO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NVNO vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
NVNO$80.57M-2.42%-2.81x3.23x
ASXC$80.62M+2.69%-0.92x1.71x
MYO$81.40M+11.64%-6.27x7.38x
MGRM$81.56M+0.38%N/A6.87x
AMIX$78.37M-4.86%N/A-14.01x

Envveno Medical Stock FAQ

What is Envveno Medical's quote symbol?

(NASDAQ: NVNO) Envveno Medical trades on the NASDAQ under the ticker symbol NVNO. Envveno Medical stock quotes can also be displayed as NASDAQ: NVNO.

If you're new to stock investing, here's how to buy Envveno Medical stock.

What is the 52 week high and low for Envveno Medical (NASDAQ: NVNO)?

(NASDAQ: NVNO) Envveno Medical's 52-week high was $6.77, and its 52-week low was $2.51. It is currently -10.64% from its 52-week high and 141.04% from its 52-week low.

How much is Envveno Medical stock worth today?

(NASDAQ: NVNO) Envveno Medical currently has 13,317,000 outstanding shares. With Envveno Medical stock trading at $6.05 per share, the total value of Envveno Medical stock (market capitalization) is $80.57M.

Envveno Medical stock was originally listed at a price of $131.00 in May 31, 2018. If you had invested in Envveno Medical stock at $131.00, your return over the last 5 years would have been -95.38%, for an annualized return of -45.94% (not including any dividends or dividend reinvestments).

How much is Envveno Medical's stock price per share?

(NASDAQ: NVNO) Envveno Medical stock price per share is $6.05 today (as of Feb 27, 2024).

What is Envveno Medical's Market Cap?

(NASDAQ: NVNO) Envveno Medical's market cap is $80.57M, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Envveno Medical's market cap is calculated by multiplying NVNO's current stock price of $6.05 by NVNO's total outstanding shares of 13,317,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.